University of Alabama at Birmingham: Preclinical demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants

University of Alabama at Birmingham: Preclinical demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants. “The overall goal of researchers at UAB, Texas Biomedical and Aridis is to find antibodies that do not permit immune escape by mutated variants of SARS-CoV-2, the virus that causes COVID-19. This includes Omicron and any future variants of concern. It is hoped that identifying and studying such antibodies can lead to the development of vaccines that protect from all coronaviruses.”